Business
Drugmakers colluded to drive up price of anti-nausea drug by 700%
May 23, 2019Business Services, Medical Communications Business, NHS, collusion, competition, pharma
Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the price …
Pharma execs testify in front of Senate of rising drug prices
February 27, 2019Research and Development Business, Senate hearing, USA, pharma, sfc
Senior Executives from seven major pharmaceutical companies, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi and Johnson & …
AstraZeneca to retire MedImmune brand amid restructuring
February 15, 2019Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring
AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …
Top Ten most popular articles on Pharmafile.com of 2018!
December 21, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10
Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …
Novartis CEO calls for cultural shift to cater for millennial generation
December 7, 2018Medical Communications Business, company, culture, millenials. Novartis
The CEO of Swiss multinational Novartis has said that he wants to ‘un-boss’ the multi-billion pound company while relaxing the …
Novartis denies potential split with Sandoz
November 15, 2018Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers
Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …
Samsung BioLogics delisted over accounting violations
November 14, 2018Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea
South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …
Novartis cuts 20% of research projects
November 1, 2018Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research
Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …
Biogen to spin off its haemophilia business
May 4, 2016Manufacturing and Production, Research and Development, Sales and Marketing Biogen, Business, alprolix, eloctate, haemophilia, hemophilia, spin off, spin-off
Biogen (NASDAQ: BIIB) has announced plans to spin off its haemophilia business as an independent, publicly traded company. To be …
Pfizer sells nutrition business to Nestlé for $11.9 billion
April 23, 2012Business Services, Sales and Marketing Business, Lipitor, Pfizer, nestle, nutrition
Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …
Financial Reporting – it’s all a foreign language… literally!
March 18, 2011Business Services Audits, Business, Financial, Languages, Reports, Services, TranslateMedia, tax, translation
Over the last two decades technology has allowed companies to greatly increase their global reach. Within the pharmaceutical sector it …
